Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
High-tech approach solves ‘real mystery’ in many cancers.
Guided by evolution, scientists create more potent antiviral that unexpectedly continues blocking dissimilar viruses.
Tumors that turn off androgen receptor may have turned on new drug target.
The #NWMetsConf connects metastatic breast cancer patients with trials, treatments, tools and each other.
Engineered immune cells get a helping hand in a new clinical trial for multiple myeloma patients.
Engineered T cells kept leukemia from returning in 12 high-risk patients.
Experts discuss rapid changes in cancer treatment and in the management of infections that can accompany these therapies.
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life.
A first-of-its-kind rapid autopsy program helps reveal the deadly disease’s potential vulnerabilities.
The first unequivocal proof in humans of immune cells’ cancer-curing power laid the groundwork for cancer immunotherapy.
Seven takeaways from community symposium highlighting recent advances in prevention, screening and treatment
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations.
High-dose radiation, younger age increase risk of developing subsequent cancer, new study finds
Nancy Davidson, MD, on improving outcomes for women with breast, lung and colorectal cancer
‘To have your life-threatening cancer cured, and then to die of not being able to breathe? It’s devastating.’
The CASSINI Trial could inform new guidelines for diagnosing, preventing and treating cancer patients at high risk of developing blood clots
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.